Baptist Health of Northeast Florida Launches Digital Platform from Gozio Health

New Baptist Access app provides seamless digital connection for better patient experiences

Baptist Health in Jacksonville, Florida, has launched its industry-leading, customizable location-aware digital health platform. The news was announced by Gozio Health.

Patient and visitors of Baptist Health can now access the new Baptist Access app, powered by the Gozio platform, providing a seamless digital connection to improve access to care and patient experiences inside hospitals and across more than 150 outpatient locations.

Baptist Health’s initial go-live aims to optimize the patient’s journey at all main access points of the health system—a strategy aligning with research that suggests digital offerings play an important role in overall patient experience and retention. By downloading the app, patients gain greater control of their care journey through digital connectivity that touches everything from accessing patient records and finding a location to appointment scheduling, physician directories and emergency department wait times.

“We’re excited to kick off 2022 with the introduction of the Baptist Access app, underscoring Baptist Health’s ongoing commitment to innovatively improving patient experiences,” said Michael A. Mayo, DHA, FACHE, president and CEO of Baptist Health. “Today, we’re used to having information right at our fingertips. With Baptist Access, our patients will have the latest information from Baptist Health to make accessing care easy.”

The Gozio platform includes robust functionality such as GPS-like turn-by-turn directions that guide patients from their homes to the appropriate parking location and patented indoor navigation capabilities that ensure visitors reach their destination inside each hospital with ease. Patient flow capabilities ensure they are guided to locations in the order they need to be accessed. The Baptist Access app also makes it easy to find onsite amenities, from restaurants to restrooms to ATMs.

“Health systems that understand where the market is moving in terms of digital engagement are investing in strategies and infrastructures that align with current trends to gain a competitive edge,” said Joshua Titus, CEO and founder of Gozio Health. “We appreciate the opportunity to work with forward-thinking organizations like Baptist Health as they define the future of patient engagement in healthcare.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”